Pacira BioSciences, Inc.
PCRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001396814
In the last 90 days, Pacira BioSciences, Inc. insiders filed 0 open-market purchases and 1 sale; 254 institutions reported holding it in 13F filings for Q2 2026, worth $1.11B in total; no superinvestor holds it.
Superinvestors holding PCRX, Q2 2026
No superinvestor reported holding PCRX in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of PCRX each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q3 2023
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q2 2023
1 superinvestor holding at quarter end
Q3 2021
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q2 2021
1 superinvestor holding at quarter end